The complaint states: Defendants set on a course to create and expand the market for weight-loss medication by advocating for obesity to be classified as a disease and thereby expanding the market for their drugs...[they implemented] multifaceted marketing campaigns that were so effective they engrained these drugs in the pop culture zeitgeist, and spending untold millions in an effort to get weight-loss medications covered under public and private insurance
We evaluated the quality of evidence using grading of recommendations assessment, development and evaluation (GRADE) criteria
This research shows us that they might be useful to manage food preoccupation and binge eating, but not in their current form. Although this study only featured the data from one person taking tirzepatide, it provides compelling data about how GLP-1 and GIP inhibitors alter electrical signals in the brain, said co-first author Wonkyung Choi, a PhD candidate in Halperns lab
Furthermore, we discuss the possible mechanisms involved in the beneficial effects of nutrition on the brain after ES, including neuroinflammation, oxidative stress, hypothalamus-pituitary-adrenal axis regulation and the microbiome-gut-brain axis
L-carnitine in all its forms exhibits neuroprotective effects
Major Findings: Produced significant dose-dependent reductions in HbA1c
